Tinnitus: Difference between revisions

(Expanded with concise EM-focused content: red flags for pulsatile tinnitus, ototoxic meds, sudden SNHL urgency, evaluation, disposition)
(Strip excess bold)
Line 2: Line 2:
*Perception of sound without external stimulation
*Perception of sound without external stimulation
*Can be constant or pulsatile, high or low pitched, hissing, clicking, or ringing
*Can be constant or pulsatile, high or low pitched, hissing, clicking, or ringing
*Most ED presentations are benign, but key EM role is to identify '''dangerous causes''':
*Most ED presentations are benign, but key EM role is to identify dangerous causes:
**'''Pulsatile tinnitus''' → vascular lesion (carotid dissection, AVM, dural AV fistula)
**Pulsatile tinnitus → vascular lesion (carotid dissection, AVM, dural AV fistula)
**'''Acute tinnitus with hearing loss''' → sudden sensorineural hearing loss (ENT emergency)
**'''Acute tinnitus with hearing loss''' → sudden sensorineural hearing loss (ENT emergency)
**'''Tinnitus after medication change''' → ototoxicity (especially [[salicylate toxicity]])
**Tinnitus after medication change → ototoxicity (especially [[salicylate toxicity]])


==Clinical Features==
==Clinical Features==
Line 39: Line 39:


===Ototoxic Medications===
===Ototoxic Medications===
*'''[[Salicylate toxicity]]''': tinnitus is an early symptom — check salicylate level
*[[Salicylate toxicity]]: tinnitus is an early symptom — check salicylate level
*Loop [[diuretics]] ([[furosemide]], [[bumetanide]], ethacrynic acid)
*Loop [[diuretics]] ([[furosemide]], [[bumetanide]], ethacrynic acid)
*[[Aminoglycosides]], [[erythromycin]], [[vancomycin]]
*[[Aminoglycosides]], [[erythromycin]], [[vancomycin]]
Line 50: Line 50:
*Auscultate over periauricular area, orbits, and neck for bruits (objective tinnitus)
*Auscultate over periauricular area, orbits, and neck for bruits (objective tinnitus)
*Cranial nerve exam, hearing (Weber/Rinne), cerebellar function
*Cranial nerve exam, hearing (Weber/Rinne), cerebellar function
*'''Pulsatile tinnitus''': CT/CTA or MRI/MRA to evaluate for vascular cause
*Pulsatile tinnitus: CT/CTA or MRI/MRA to evaluate for vascular cause
*'''Acute unilateral hearing loss + tinnitus''': audiometry referral urgently (sudden SNHL)
*Acute unilateral hearing loss + tinnitus: audiometry referral urgently (sudden SNHL)
*'''Salicylate level''' if aspirin use or toxicity suspected
*Salicylate level if aspirin use or toxicity suspected
*Other workup guided by history (BMP, TSH, CBC, head CT if trauma or neurologic deficits)
*Other workup guided by history (BMP, TSH, CBC, head CT if trauma or neurologic deficits)


Line 58: Line 58:
*Identify and treat reversible causes
*Identify and treat reversible causes
*Stop/minimize ototoxic agents
*Stop/minimize ototoxic agents
*'''Salicylate toxicity''': treat per [[salicylate toxicity]] protocol
*Salicylate toxicity: treat per [[salicylate toxicity]] protocol
*'''Sudden sensorineural hearing loss''': urgent ENT referral (may benefit from systemic or intratympanic steroids if started within 2 weeks)
*Sudden sensorineural hearing loss: urgent ENT referral (may benefit from systemic or intratympanic steroids if started within 2 weeks)
*'''Cerumen impaction''': removal often provides relief
*Cerumen impaction: removal often provides relief
*Outpatient: masking techniques (white noise), habituation therapy, consider antidepressants for severe cases
*Outpatient: masking techniques (white noise), habituation therapy, consider antidepressants for severe cases
*Reassurance for most patients
*Reassurance for most patients

Revision as of 09:35, 22 March 2026

Background

  • Perception of sound without external stimulation
  • Can be constant or pulsatile, high or low pitched, hissing, clicking, or ringing
  • Most ED presentations are benign, but key EM role is to identify dangerous causes:
    • Pulsatile tinnitus → vascular lesion (carotid dissection, AVM, dural AV fistula)
    • Acute tinnitus with hearing loss → sudden sensorineural hearing loss (ENT emergency)
    • Tinnitus after medication change → ototoxicity (especially salicylate toxicity)

Clinical Features

  • Subjective (only patient hears) vs. objective (examiner can hear — think vascular or mechanical cause)
  • Pulsatile vs. non-pulsatile
  • Unilateral vs. bilateral
  • Associated hearing loss, vertigo, fullness (Meniere's disease)
  • Associated headache, visual changes, papilledema (idiopathic intracranial hypertension)
  • Medication review for ototoxic agents

Red Flags

  • Pulsatile tinnitus (vascular cause until proven otherwise)
  • Unilateral tinnitus with hearing loss (acoustic neuroma, sudden SNHL)
  • Associated neurologic deficits (stroke, dissection)
  • Recent head trauma
  • Suicidal ideation (severe tinnitus is a risk factor)

Differential Diagnosis

Objective (May Be Heard by Examiner)

  • Vascular (often pulsatile): AVM, aneurysm, arterial bruits, carotid stenosis or dissection, dural AV fistula
  • Mechanical: enlarged eustachian tube, palatal myoclonus, stapedial muscle spasm

Subjective

Ototoxic Medications

Evaluation

  • Otoscopic exam (cerumen impaction, otitis media, TM perforation)
  • Auscultate over periauricular area, orbits, and neck for bruits (objective tinnitus)
  • Cranial nerve exam, hearing (Weber/Rinne), cerebellar function
  • Pulsatile tinnitus: CT/CTA or MRI/MRA to evaluate for vascular cause
  • Acute unilateral hearing loss + tinnitus: audiometry referral urgently (sudden SNHL)
  • Salicylate level if aspirin use or toxicity suspected
  • Other workup guided by history (BMP, TSH, CBC, head CT if trauma or neurologic deficits)

Management

  • Identify and treat reversible causes
  • Stop/minimize ototoxic agents
  • Salicylate toxicity: treat per salicylate toxicity protocol
  • Sudden sensorineural hearing loss: urgent ENT referral (may benefit from systemic or intratympanic steroids if started within 2 weeks)
  • Cerumen impaction: removal often provides relief
  • Outpatient: masking techniques (white noise), habituation therapy, consider antidepressants for severe cases
  • Reassurance for most patients

Disposition

  • Discharge unless underlying condition requires admission
  • Urgent ENT referral for: sudden hearing loss, pulsatile tinnitus, unilateral tinnitus concerning for acoustic neuroma
  • Return precautions: hearing loss, new neurologic symptoms, vertigo, worsening

See Also

References